Menu
Back to Journals » Drug Design, Development and Therapy » Volume 13
Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway [Corrigendum]
Mu M, Zuo S, Wu RM, et al. Drug Des Devel Ther. 2018;12:4107–4115.
An error has been found in a couple of the image labels for Figure 3F. On page 4112, the original Figure 3F image appears as:
© 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.